AAV-MyoAAV 4A vector system (AAV-MyoAAV 4A expression system, AAV-MyoAAV 4A packaging plasmid system)
GeneMedi (GM) AAV-MyoAAV 4A Vector system is including: 1) AAV-MyoAAV 4A Rep-Cap plasmid (AAV-MyoAAV 4A-RC plasmid) 2) AAV Helper plasmid 3) AAV expression vectors (overexpression or shRNA).
You can produce AAV-MyoAAV 4A particle in 293T cell line in high titer using GeneMedi's AAV-MyoAAV 4A Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
Product Description
Cat.NO | Product Name | Organization Type | Price(In USD) | Qty (Quantity) | Sum(In USD) |
---|---|---|---|---|---|
P-PK33 | AAV-MyoAAV 4A Vector System 1. MyoAAV 4A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 3379 | ||
P-PK33 | AAV-MyoAAV 4A Vector System 1. MyoAAV 4A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
P-PK33 | AAV-MyoAAV 4A Vector System 1. MyoAAV 4A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
P-RC33 | AAV-MyoAAV 4A Rep-Cap
Plasmid
|
Academic | 2062 | ||
P-RC33 | AAV-MyoAAV 4A Rep-Cap
Plasmid
| Industry R&D (excluding CRO&CDMO&CXO) |
|||
P-RC33 | AAV-MyoAAV 4A Rep-Cap
Plasmid
| CRO&CDMO& CXO&CMC& Manufacturing company |
|||
If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
Shipping Cost: | 169.00 | ||||
Total: | |||||
Citation
Title | Publication | Date |
---|---|---|
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARa and Inhibition of p53-Mediated Senescence | Cancer Cell | 2017/5/8 |
Laterodorsal tegmentum interneuron subtypes oppositely regulate olfactory cue-induced innate fear | NATURE NEUROSCIENCE | 2016/6/26 |
HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells | Signal Transduction and Targeted Therapy | 2021/11/24 |
Genetic and Pharmacological Inhibition of Astrocytic Mysm1 Alleviates Depressive‐Like Disorders by Promoting ATP Production | Advanced Science | 2022/11/22 |
Skin chronological aging drives age-related bone loss via secretion of cystatin-A | Nature Aging | 2022/10/6 |
Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis | Science Advances | 2023/2/8 |
Capturing dynamic biological signals via bio-mimicking hydrogel for precise remodeling of soft tissue | Bioactive Materials | 2021/5/11 |
A novel circular RNA, circIgfbp2, links neural plasticity and anxiety through targeting mitochondrial dysfunction and oxidative stress-induced synapse dysfunction after traumatic brain injury | Molecular Psychiatry | 2022/8/2 |
Extracellular vesicle-derived CircWhsc1 Promotes Cardiomyocyte Proliferation and Heart Repair by activating TRIM59/STAT3/Cyclin B2 pathway | Journal of Advanced Research | 2022/12/29 |
Circular RNA CREBBP modulates cartilage degradation by activating the Smad1/5 pathway through the TGFβ2/ALK1 axis | Experimental & Molecular Medicine | 2022/10/12 |
Validation data
No data found
Associated products and services
Products & Service | Products & Service Information |
---|---|
AAV Packaging service | Detail |
Promise-ORF™ viral CDNA library | Detail |
Plasmid DNA Rapid Preparation Service | Detail |